Skip to main content

Table 4 Subgroup analysis of OS and DFS in 255 patients with SLM after NAC

From: Timing of surgery in patients with synchronous colorectal cancer liver metastases undergoing neoadjuvant chemotherapy: a propensity score analysis

Clinical indicators

Time interval (TI) after NAC to surgery (no. of patients)

OS (mean survival time)

P value

DFS (mean disease-free time)

P value

Age

 Age < 60

4TI < 6 (N = 61)

35.94 months

0.055

29.43 months

0.113

6TI8 (N = 64)

28.35 months

 

21.73 months

 

 Age ≥ 60

4TI < 6 (N = 71)

35.37 months

0.011*

27.93 months

0.002*

6TI8 (N = 59)

26.22 months

 

18.91 months

 

Chronic disease

 Yes

4TI < 6 (N = 52)

37.46 months

0.012*

28.64 months

0.019*

6TI8 (N = 46)

28.45 months

 

20.25 months

 

 No

4TI < 6 (N = 80)

34.50 months

0.045*

29.29 months

0.014*

6TI8 (N = 77)

27.74 months

 

20.34 months

 

Anemia (M:Hb < 120 g/L,F:Hb < 110 g/L)

 Yes

4TI < 6 (N = 64)

35.75 months

0.052

25.98 months

0.063

6TI8 (N = 45)

26.39 months

 

19.29 months

 

 No

4TI < 6 (N = 68)

36.16 months

0.030*

31.63 months

0.007*

6TI8 (N = 78)

27.49 months

 

20.32 months

 

Preoperative jaundice

 Yes

4TI < 6 (N = 73)

36.39 months

0.062

30.94 months

0.001*

6TI8 (N = 40)

27.50 months

 

16.92 months

 

 No

4TI < 6 (N = 59)

34.18 months

0.036*

26.63 months

0.069

6TI8 (N = 83)

27.50 months

 

22.92 months

 

 Exclude non-R0 resection

4TI < 6 (N = 125)

35.44 months

0.007*

29.45 months

0.002*

6TI8 (N = 110)

27.88 months

 

20.27 months

 
  1. *p<0.05